Mission Pharmacal's new products showcase emission reduction of HFCs at White House Roundtable

SAN ANTONIO — Mission Pharmacal on Tuesday participated in a White House Industry Leadership Roundtable discussion on ways to curb emissions of hydrofluorocarbons, using its recently launched zinc oxide aerosol spray products as an example to help set the environmental standard for aerosol performance, the company stated. 

 

The Dr. Smith's line of aerosol spray products contain Honeywell's patented Solstice Propellant to bring to market three new products used in the treatment and prevention of diaper rash and associated skin irritations in babies, adults and seniors.

 

"Mission Pharmacal always looks for ways to create innovative healthcare products," stated Neill Walsdorf, Jr., president of Mission Pharmacal. "Honeywell Solstice Propellant, with its environmental and safety profile, brings value to Dr. Smith's brand while vastly reducing environmental impact. This is a great product for moms and Mother Earth."

 

The three Dr. Smith's spray products are the first zinc oxide aerosol products available in the health-and-wellness category that are formulated with the Solstice Propellant, which is non-flammable, has ultra-low global warming potential, is not an HFC and is not a volatile organic compound. According to the company, Solstice Propellant has a GWP of less than 1, which is 99% lower than the GWP of HFC-134a, one of the most common propellants on the market today. 

 

Formulated Solutions, the manufacturer of these aerosol sprays, also played an important role in the development of these products.